Abstract

BackgroundAfter the new definition of adjustment disorder (AjD) by the International Classification of Diseases-11(ICD-11), AjD has attracted more and more attention. Adjustment disorder new module-20 (ADNM-20), which is used to diagnose AjD, has been verified in some countries, but it has not been verified in China. As a result, the purpose of this study was to investigate the validity and reliability of the Chinese version of the Adjustment disorder new module-20 (ADNM-20) in female breast cancer patients.MethodsThe ADNM-20 translated into Chinese employed the translation and back translation technique. Three hundred fifty four newly diagnosed (< 1 year) female breast cancer patients were recruited from Tongji Hospital and Hubei Cancer Hospital in Hubei, China. The patients completed the self-report questionnaire including demographic characteristics and the scale ADNM-20. Data on psychometric properties were evaluated in terms of internal consistency, item-total correlations, test-retest reliability, and factorial validity.ResultsADNM-20 core symptoms included 8 items and two factors, which were extracted by using exploratory factor analysis (EFA). It could explain 61.74% of the total variance. ADNM-20 accessory symptoms including 12 items and four factors, which were extracted by using EFA. It could explain 68.34% of the total variance. Cronbach’s α coefficient for ADNM-20 was 0.93, split-half reliability was 0.87, and the test-retest correlation coefficient was 0.74. The correlation coefficient between each subscale was ranged from 0.53 to 0.71 (P < 0.01), while the correlation coefficient between the subscales and total scale was ranged from 0.79 to 0.89 (P < 0.01).ConclusionsThe study verified the validity and reliability of the Chinese version of ADNM-20. It is applicable to measure the prevalence of adjustment disorder in the breast cancer population.

Highlights

  • After the new definition of adjustment disorder (AjD) by the International Classification of Diseases11(ICD-11), AjD has attracted more and more attention

  • Discrepancies between the translations were discussed by the above two experts and corrections were made on mutual agreement, and the Chinese version of Adjustment disorder new module-20 (ADNM-20) was generated according to the suggestions of them [20]

  • The score of Adjustment Disorder New Moudle (ADNM)-20 was different through different occupations (P < 0.01)

Read more

Summary

Introduction

After the new definition of adjustment disorder (AjD) by the International Classification of Diseases11(ICD-11), AjD has attracted more and more attention. Adjustment disorder new module-20 (ADNM-20), which is used to diagnose AjD, has been verified in some countries, but it has not been verified in China. The purpose of this study was to investigate the validity and reliability of the Chinese version of the Adjustment disorder new module-20 (ADNM-20) in female breast cancer patients. AjD is a common comorbidity in cancer patients. A meta-analysis indicated that the prevalence of AjD in cancer patients was 15.4% [4]. Hund et al found that except head and neck cancer, breast cancer had the highest prevalence of AjD was than other cancer, so this group should receive more attention [5]. The 5-year and 10-year survival rates of breast cancer were 87 and 82%, respectively [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call